🔎 Trials Near Me

Beranda › Glaucoma Sudut Terbuka › Florida

Uji klinis Glaucoma Sudut Terbuka di Florida

6 studi untuk Glaucoma Sudut Terbuka mencari peserta di lokasi di Florida.

Teks studi resmi (Bahasa Inggris)

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

  • Brandon Eye Associates - Brandon /ID# 277074, Brandon
  • East Coast Institute for Research /ID# 280411, Jacksonville
Menerima pesertaFase 3
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06822738

REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension

  • Advanced Research, Deerfield Beach
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07675824

A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension

  • Advanced research, LLC, Boynton Beach
  • Advanced research, LLC, Weston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07661329

DSLT for Reducing Medication in Glaucoma

  • The Eye Institute of West Florida, Largo
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT07390890

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

  • Bascom Palmer Eye Institute, Miami
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT07217678

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

  • Volusia Eye Associates, New Smyrna Beach
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2022 · NCT05401357

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.